Meeting NewsVideo

VIDEO: Novartis updates product pipeline

VANCOUVER, British Columbia — Dirk Sauer, PhD, Novartis global head of research and development, gives an update on the company’s portfolio, including Luxturna, brolucizumab and a possible presbyopia treatment, at the Association for Research in Vision and Ophthalmology meeting.

VANCOUVER, British Columbia — Dirk Sauer, PhD, Novartis global head of research and development, gives an update on the company’s portfolio, including Luxturna, brolucizumab and a possible presbyopia treatment, at the Association for Research in Vision and Ophthalmology meeting.

    See more from Association for Research in Vision and Ophthalmology